Modified cell cycle status in a mouse model of altered neuronal vulnerability (Wallerian degeneration slow: WLDs)

T. M. Wishart, H.N. Pemberton, S. R. James, C. J. McCabe, T. H. Gillingwater

Research output: Contribution to journalArticlepeer-review

Abstract

Altered neuronal vulnerability underlies many diseases of the human nervous system, resulting in degeneration and loss of neurons. The neuroprotective Wallerian Degeneration Slow (Wld(s)) mutation delays degeneration in axonal and synaptic compartments of neurons following a wide range of traumatic and disease-inducing stimuli, providing a powerful experimental tool with which to investigate modulation of neuronal vulnerability. Although the mechanisms through which Wlds confers neuroprotection remain unclear a diverse range of downstream modifications, incorporating several genes/pathways, have been implicated. These include: elevated NAD levels associated with nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1; a part of the chimeric Wld(s) gene);altered mRNA expression levels of genes such as pituitary tumor transforming gene 1 (Pttg1); changes in the location/activity of the ubiquitin-proteasome machinery via binding to valosin-containing protein (VCP/p97); and modified synaptic expression of proteins such as ubiquitin- activating Enzyme E1 (Ube1).
Original languageEnglish
Article numberR101
JournalGenome Biology
Volume9
Issue number6
DOIs
Publication statusPublished - Jun 2008

Fingerprint

Dive into the research topics of 'Modified cell cycle status in a mouse model of altered neuronal vulnerability (Wallerian degeneration slow: WLDs)'. Together they form a unique fingerprint.

Cite this